Panelists discuss how the expanding treatment landscape for Crohn’s disease includes multiple mechanisms of action such as anti-tumor necrosis factor (TNF) agents, anti-integrin agents, interleukin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback